Exam Details

Subject pharmaceutical analysis iii
Paper
Exam / Course b.pharm
Department
Organization Gujarat Technological University
Position
Exam Date May, 2017
City, State gujarat, ahmedabad


Question Paper

1/2
Seat No.: Enrolment
GUJARAT TECHNOLOGICAL UNIVERSITY
B.PHARM.-SEMESTER-VII- EXAMINATION -SUMMER-2017
Subject code: 270004 Date: 05/05/2017
Subject Name: Pharmaceutical Analysis III
Time: 02:30 PM to 05:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1

Explain Beer Lambert's law. Derive its equation and state its limitations.
06

Discuss structural features that may produce bathochromic or hypsochromic shift in UV spectrum of an organic compound.
05

Calculate following.
1. One liter solution is prepared by dissolving 0.1235 g of substance A (Mol. weight 214.3 g/mole) in sufficient methanol. The absorbance of resulting solution at 235 nm is found to be 0.824 in 1 cm cell. Calculate the molar absorptivity of substance A.
2. Predict the absorption maximum of the following compound from the structure using Woodward-Feiser law.
05
Q.2

Explain the terms with reference to EMR: Diffraction, Reflection and Refraction.
06

Discuss the working of hollow-cathode lamp with labeled diagram.
05

Twenty paracetamol tablets having average weight 0.65 g are finely powdered. Accurately weighed 0.13 g of tablet powder is sonicated with 25 mL 0.1 M sodium hydroxide solution, diluted up to 100 mL with distilled water and filtered. To 1 mL of filtrate, 10 mL of 0.1M sodium hydroxide is added and diluted to 100 mL with distilled water. Absorbance of resulting solution measured on UV-Visible spectrophotometer at 257 nm wavelength using 1 cm quartz cell is found to be 0.644. Calculate the content of paracetamol in sample tablets (in terms of of labeled claim) taking 715 as the specific absorbance at 257 nm. Labeled claim of tablets is 500 mg of paracetamol.
05
Q.3

Explain design and working of ICP torch. Describe the methods of introducing samples in ICP torch.
06

Explain the theory of fluorescence and phosphorescence with reference to the Jablonski diagram.
05

Quinine in 1.664 g antimalarial tablet was dissolved in sufficient 0.1M HCl to give 500 mL of solution. A 20.00 mL aliquot was then diluted to 100.0 mL with the acid. The fluorescence intensity of this test sample at 347.5 nm provided a reading of 245 on an arbitrary scale. A standard 100 ppm quinine solution
HO
2/2
registered 125 when measured under conditions identical to those for test sample. Calculate the mass in mg of quinine in the tablet.
05
Q.4

Discuss the factors affecting IR absorption frequencies.
06

Define and classify fundamental molecular vibrations with examples.
05

Attempt following.
1. Explain the statement: IR absorption due to carbonyl stretching occurs at higher frequencies than stretching of carbon-carbon double bond.
2. How will you differentiate between acetone, acetic acid and dimethyl ether using IR spectroscopy?
05
Q.5

Explain general fragmentation rules applicable to electron impact source in mass spectrometry.
06

Explain the working of following mass analyzers
1. Quadrupole
2. Time of flight
05

Write a short note on
1. Mc-Lafferty rearrangements
2. MALDI
05
Q. 6

Explain the term 'chemical shift'. Discuss the factors affecting chemical shift with suitable examples.
06

Write a brief note on C13 NMR spectroscopy.
05

Predict number of signals and splitting pattern in H1 NMR spectrum of isopropyl chloride and p-methoxy toluene.
05
Q. 7

Define the terms: Bathochromic shift, Stokes shift, Atomization, Mass to charge ratio, Fermi resonance, Quenching
06

Calculate following.
1. Calculate the frequency in hertz and the energy in joules/photon of an EMR with a wavelength of 530 nm.
(plank constant h 6.63 x 10-34 J.s)
2. Convert the following absorbances in to transmittance.
a. 0.278
b. 0.039
c. 1.499
05

Suggest a structure for an organic compound having molecular formula C8H11N that shows the following spectral data.
IR: sharp band at 3400 absorption near 3100 cm-1 and 2950 bands around 1400, 1500 and 1600 cm-1 and two strong bands around 700 and 750 cm-1.
NMR: a five proton multiplet at δ 6.5-7.5, a triplet-quartet pattern at δ 1.2 and δ 3.1 respectively, a sharp singlet at δ 3.3
MS: A molecular ion peak at m/z 121 and a base peak at m/z 106.
05



Subjects

  • agronomy and forestry of medicinal plants
  • anatomy physiology & health education -ii
  • anatomy, physiology and health education (aphe)
  • applied mathematics (biostatistics)
  • basic computer applications
  • basic concepts of pharmacology and clinical pharmacy practice
  • basics of computer applications
  • bioavailability & therapeutic drug monitoring
  • bioavailability and therapeutic drug monitoring
  • biochemistry
  • clinical pharmacy ii
  • clinical pharmacy-i
  • commerce of herbs and phytoconstitutents
  • computer applications in drug discovery
  • current advances in novel drug delivery systems
  • cyber security
  • disaster management
  • dispensing pharmacy i
  • dispensing pharmacy i and drug store management
  • dispensing pharmacy ii and pharma industrial management
  • dosage form design –i
  • dosage form design- i
  • dosage form design- ii
  • dosage form design-i
  • dosage form design-ii
  • drug approval process
  • environmental studies
  • environmental toxicology and green audit
  • food analysis
  • forensic pharmacy
  • forensic pharmacy-i
  • genetic engineering and gene therapy
  • green chemistry
  • health education and community health
  • herbal cosmetics
  • hospital and community pharmacy
  • hospital management and medical tourism
  • hospital pharmacy, community pharmacy & forensic pharmacy
  • hospital pharmacy, community pharmacy and dispensing pharmacy-ii
  • human anatomy physiology
  • human anatomy physiology and health education-ii
  • human anatomy physiology-ii
  • human anatomy, physiology and health education - i
  • innovations in conventional drug delivery system
  • instrumental and process validation
  • intellectual property rights and patents
  • medical writing and coding
  • medicinal biochemistry
  • nutraceuticals
  • pathophysiology
  • pharmaceutical analysis ii
  • pharmaceutical analysis iii
  • pharmaceutical analysis iv
  • pharmaceutical analysis-i
  • pharmaceutical analysis-ii
  • pharmaceutical analysis-iv
  • pharmaceutical chemistry – ii
  • pharmaceutical chemistry – vi (organic chemistry – ii)
  • pharmaceutical chemistry –viii (medicinal chemistry - ii)
  • pharmaceutical chemistry iii
  • pharmaceutical chemistry iv
  • pharmaceutical chemistry vii
  • pharmaceutical chemistry-i
  • pharmaceutical chemistry-i (inorganic chemistry)
  • pharmaceutical chemistry-ii (physical chemistry)
  • pharmaceutical chemistry-iii (biochemistry – i)
  • pharmaceutical chemistry-iv (organic chemistry-i)
  • pharmaceutical chemistry-ix (medicinal chemistry-iii)
  • pharmaceutical chemistry-v
  • pharmaceutical chemistry-v (biochemistry-ii)
  • pharmaceutical chemistry-vi (medicinal)
  • pharmaceutical chemistry-vii
  • pharmaceutical chemistry-viii
  • pharmaceutical chemistry-x
  • pharmaceutical chemistry-x (medicinal chemistry-iii)
  • pharmaceutical engineering
  • pharmaceutical engineering-ii
  • pharmaceutical inorganic chemistry
  • pharmaceutical marketing management
  • pharmaceutical microbiology - i
  • pharmaceutical microbiology & biotechnology i
  • pharmaceutical microbiology &biotechnology- ii
  • pharmaceutical microbiology and biotechnology - ii
  • pharmaceutical organic chemistry
  • pharmaceutical technology - i
  • pharmaceutical technology – i
  • pharmaceutical technology- ii
  • pharmaceutical technology-i
  • pharmaceutical technology-ii
  • pharmaceutics-i
  • pharmaceutics-ii
  • pharmaceutivcal chemistry ix
  • pharmacognosy iii
  • pharmacognosy iv
  • pharmacognosy vi
  • pharmacognosy vii
  • pharmacognosy vii (herbal formulations & complimentary therapies)
  • pharmacognosy-i
  • pharmacognosy-ii
  • pharmacognosy-iii
  • pharmacognosy-iv
  • pharmacognosy-v
  • pharmacognosy-v (plant bio technology)
  • pharmacognosy-vi
  • pharmacology -iii
  • pharmacology & pharmacotherapeutics-ii
  • pharmacology and pharmacotherapeutics - i
  • pharmacology and pharmacotherapeutics - iii
  • pharmacology and pharmacotherapeutics-iv
  • pharmacology-i
  • pharmacology-ii
  • pharmacovigilance
  • pharmacy practice
  • physical pharmaceutics-ii
  • physical pharmacy
  • quality by design (qbd) and process analytical technology (pat)
  • regulatory aspects of food and neutraceuticals
  • remedial mathematics
  • unit operation - i
  • unit operation - ii